The Food and Drug Administration announced on July 21 that a former pharmaceutical executive will direct its drug evaluation center.
Dr. George Tidmarsh, an adjunct professor at Stanford University, will lead the FDA’s Center for Drug Evaluation and Research (CDER), the FDA said in a statement.
Tidmarsh was president and CEO of La Jolla Pharmaceutical Company from early 2012 until late 2019, during which time the company secured FDA approval of a hormone called angiotensin II for patients suffering from shock. He also founded and served as CEO of Horizon Pharma Inc., helping to shepherd a drug for rheumatoid arthritis through the FDA approval process….